DaVita HealthCare Partners Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -26.4% | -127.7% | – | +1.4% | -32.4% | -67.1% | +80.2% | +159.4% | -35.7% | -40.7% | +52.7% | – | |
| – | +3.6% | -4.2% | -6.1% | +6.5% | -6.9% | +1.3% | -1.0% | +1.6% | +5.2% | -4.8% | -5.6% | – | |
| – | +10.9% | -18.4% | -1.0% | +9.3% | +3.1% | +8.6% | +10.2% | +18.8% | -1.5% | -26.7% | -7.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -89.8% | -6,075.4% | – | -1.7% | -77.5% | -573.1% | – | – | -121.6% | – | – | – | |
| – | +16.2% | -23.9% | +3.1% | +11.5% | +22.7% | -16.1% | -15.5% | +37.2% | -12.4% | -29.9% | +66.5% | – | |
| – | +22.5% | +25.6% | -24.8% | -9.4% | +69.3% | -34.6% | -58.8% | +293.9% | -38.0% | -14.7% | +39.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -11,462.5% | -10.1% | +44.1% | +43.9% | -29.8% | +48.3% | -16.5% | -91.2% | +1,807.7% | -47.8% | -8.0% | – | |
| – | – | – | – | – | -113.4% | – | +84.2% | -104.7% | – | +982.0% | -54.4% | – | |
| – | +1.8% | – | -276.4% | -98.6% | +7,091.4% | -32.3% | – | -15,135.9% | -28.7% | -48.5% | +26.6% | – | |
| – | -165.5% | – | – | +804.4% | -142.5% | – | – | -100.6% | – | – | – | – | |
| – | -37.5% | -178.1% | – | -0.4% | -43.8% | -90.3% | +453.2% | +232.2% | -41.5% | -44.6% | +46.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.